Jifang Gong

Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim results

Changsong Qi, Jifang Gong, Jian Li et al. · Nature Medicine · 2022 · 571 citations · Full text

Medicine, Oncology, Pharmacokinetics +17

The Gut Microbiome Is Associated with Clinical Response to Anti–PD-1/PD-L1 Immunotherapy in Gastrointestinal Cancer

Zhi Peng, Siyuan Cheng, Yan Kou et al. · Cancer Immunology Research · 2020 · 351 citations

Life Sciences, Microbiology, Oncology +17

Reduced m6A modification predicts malignant phenotypes and augmented Wnt/PI3K‐Akt signaling in gastric cancer

Cheng Zhang, Mengqi Zhang, Sai Ge et al. · Cancer Medicine · 2019 · 320 citations · Full text

Medicine, Molecular Biology, Oncology +17

Predicting response to immunotherapy in gastric cancer via multi-dimensional analyses of the tumour immune microenvironment

Yang Chen, Keren Jia, Yu Sun et al. · Nature Communications · 2022 · 199 citations · Full text

Medicine, Immunology, Oncology +17

Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial

Xiangyu Gao, Nong Xu, Ziyu Li et al. · The Lancet Oncology · 2023 · 197 citations

Pharmacy, Oncology, Pharmacology +16